Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression By: CNBC.com News March 08, 2023 at 23:34 PM EST Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms. Read More >>
